Resonance Health is pleased to announce today that it has signed an Alliance Partner Agreement with Blackford Analysis.

Blackford provides a single platform that enables healthcare providers to quickly access and manage medical image analysis applications and AI algorithms that add clinical value. The platform allows healthcare providers to use imaging information efficiently and reduce the cost of care while improving diagnostic confidence and patient outcomes. The collaboration allows all of Blackford’s current and future customers access to Resonance Health products.

The Blackford Platform integrates directly with PACs systems used by hospitals, including those provided by channel partners such as Intelerad and eRAD. The Resonance Health product FerriSmart® will now integrate seamlessly with the Blackford Platform, allowing for easy access from existing clinical workflows to improve diagnostic confidence, reduce the cost of care, and add clinical value.

This agreement gives Blackford the right to promote, market, sell, distribute, and license FerriSmart® directly and/or via resellers. FerriScan® and HepaFat-Scan® are also listed in the agreement and Resonance Health may subsequently authorise Blackford to integrate these with, or offer these in connection with, the Blackford platform. Work will now commence to integrate FerriSmart® with the Blackford platform. Blackford provides services in the United States, Canada, UK, Australia, and New Zealand.

Blackford CEO, Ben Panter said this of the alliance: “We look forward to working with Resonance Health to provide our customers and channel partners quick access to FerriSmart through our single platform, to help provide additional clinical value for patients.”

Resonance Health’s CEO, Alison Laws commented: “Integration into existing radiology workflows will mean seamless accessibility for our products across a new customer base, allowing us to provide future customers with the highest quality data for use in the clinical management of patients. We are very pleased to be working with Blackford to deliver our services as part of the Blackford platform”.

About Blackford

Blackford provide a single platform to quickly access and manage regulatory approved medical image analysis applications and AI algorithms that add clinical value. Easily integrated into existing workflows, the platform provides actionable information that allows healthcare providers to use imaging information smartly and reduce the cost of care, while improving diagnostic confidence and patient outcomes. Founded in 2010, and with operations in the United Kingdom and the United States, Blackford Analysis is backed by TRI Cap, Old College Capital, and Archangel Investors, one of the UK’s leading business angel syndicates. For more information, visit www.blackfordanalysis.com.